Synthetic cannabinoids abused in South Korea: Drug identifications by the National Forensic Service from 2009 to June 2013

Forensic Toxicology

Volumn 32, Issue 1, 2014, Pages 82-88

  Chung, Heesun ^a   Choi, Hyeyoung ^b   Heo, Sewoong ^b   Kim, Eunmi ^b   Lee, Jaesin ^b  

^a Chungnam National University   (South Korea)

^b National Forensic Service   (South Korea)

Author keywords

Coingredients; National Forensic Service; New psychoactive substance; South Korea; Synthetic cannabinoids; XLR 11

Indexed keywords

EID: 84895185030     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-013-0213-6     Document Type: Article

References (26)

1. EMCDDA (2011) Annual report on the state of the drugs problem in Europe. European Monitoring Centre for Drugs and Drug Addiction, Lisbon
2. Hillebrand J, Olszewski D, Sedefov R (2010) Legal highs on the internet. Subst Use Misuse 45:330-340
3. Uchiyama N, Kikura-Hanajiri R, Kawamura M, Goda Y (2009) Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61-66
4. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Fereirós N (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832-837
5. UNODC (2012) World drug report 2012. United Nations Office on Drugs and Crime, Vienna
6. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Goda Y (2013) Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012. Forensic Toxicol 31:44-53
7. Zuba D, Byrska B (2013) Analysis of the prevalence and coexistence of synthetic cannabinoids in "herbal high" products in Poland. Forensic Toxicol 31:21-30
8. Mauler F, Mittendorf J, Horváth E, De Vry J (2002) Characterization of the diarylether sulfonylester (-)-(R)-3-(2- hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties. J Pharmacol Exp Ther 302:359-368
9. EMCDDA (2009) Thematic papers: understanding the "spice" phenomenon. European Monitoring Centre for Drugs and Drug Addiction, Lisbon
10. 2 cannabinoid receptor agonists: pain relief without psychoactive effects? Curr Opin Pharmacol 3:62-67
11. 2 cannabinoid receptors are implicated in inflammatory pain. Pain 96:253-260
12. 2 cannabinoid receptors. Anesthesiology 99:955-960
13. Choi H, Heo S, Kim E, Hwang BY, Lee C, Lee J (2013) Identification of (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone and its 5-pentyl fluorinated analog in herbal incense seized for drug trafficking. Forensic Toxicol 31:86-92
14. 2 receptor binding. Drug Alcohol Depend 60:133-140
15. Huffman JW, Szklennik PV, Almond A, Bushell K, Selley DE, He H, Cassidy MP, Wiley JL, Martin BR (2005) 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorg Med Chem Lett 15:4110-4113
16. Weissman A, Milne GM, Melvin LS Jr (1982) Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol. J Pharmacol Exp Ther 223:516-523
17. Harris CR, Brown A (2013) Synthetic cannabinoid intoxication: a case series and review. J Emerg Med 44:360-366
18. Patton AL, Chimalakonda KC, Moran CL, McCain KR, Radominska-Pandya A, James LP, Kokes C, Moran JH (2013) K2 toxicity: fatal case of psychiatric complications following AM2201 exposure. J Forensic Sci. doi: 10.1111/1556-4029.12216
19. Park Y, Lee C, Lee H, Pyo J, Jo J, Lee J, Choi H, Kim S, Hong RS, Park Y, Hwang BY, Choe S, Jung JH (2013) Identification of a new synthetic cannabinoid in a herbal mixture: 1-butyl-3-(2-methoxybenzoyl)indole. Forensic Toxicol 31:187-196
20. Choi H, Heo S, Choe S, Yang W, Park Y, Kim E, Chung H, Lee J (2013) Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS. Anal Bioanal Chem 405:3937-3944
21. 35S]GTPγS binding assays. Forensic Toxicol 29:132-141
22. 2 cannabinoid receptor activity. J Med Chem 53:295-315
23. Pace JM, Tietje K, Dart MJ, Meyer MD (2006) 3-Cycloalkylcarbonyl indoles as cannabinoid receptor ligands. Published in 2006-06-29, assigned to Abbott Laboratories
24. 2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging. J Pharmacol Exp Ther 328:141-151
25. Uemura N, Fukaya H, Kanai C, Yoshida M, Nakajima J, Takahashi M, Suzuki J, Moriyasu T, Nakae D (2013) Identification of a synthetic cannabinoid A-836339 as a novel compound found in a product. Forensic Toxicol. doi: 10.1007/s11419-013-0201-x
26. Shin MH (2012) Improvement of drug designation system-introduction of emergency procedure and analogue system (in Korean). J FDC Regulatory Sci 7:13-19